These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23258075)

  • 1. Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease.
    Dounousi E; Koliousi E; Papagianni A; Ioannou K; Zikou X; Katopodis K; Kelesidis A; Tsakiris D; Siamopoulos KC
    Am J Nephrol; 2012; 36(6):531-6. PubMed ID: 23258075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not all inflammatory markers are linked to kidney function: results from a population-based study.
    Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
    Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraindividual interleukin-6 variations on the cardiovascular prognosis of patients with chronic renal disease.
    Goicoechea M; Quiroga B; García de Vinuesa S; Verdalles U; Reque J; Panizo N; Arroyo D; Santos A; Macías N; Luño J
    Ren Fail; 2012; 34(8):1002-9. PubMed ID: 22746155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
    Liabeuf S; Barreto DV; Barreto FC; Chasseraud M; Brazier M; Choukroun G; Kamel S; Massy ZA
    Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients.
    Spoto B; Leonardis D; Parlongo RM; Pizzini P; Pisano A; Cutrupi S; Testa A; Tripepi G; Zoccali C; Mallamaci F
    Nutr Metab Cardiovasc Dis; 2012 Nov; 22(11):981-8. PubMed ID: 21906921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sFas/sFasL ratio as a novel marker of inflammation in children with chronic kidney disease.
    Musiał K; Zwolińska D
    Clin Chim Acta; 2012 Dec; 414():7-11. PubMed ID: 22898262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease.
    Okyay GU; Inal S; Oneç K; Er RE; Paşaoğlu O; Paşaoğlu H; Derici U; Erten Y
    Ren Fail; 2013; 35(1):29-36. PubMed ID: 23113674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease.
    Lee BT; Ahmed FA; Hamm LL; Teran FJ; Chen CS; Liu Y; Shah K; Rifai N; Batuman V; Simon EE; He J; Chen J
    BMC Nephrol; 2015 May; 16():77. PubMed ID: 26025192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased apoptosis of peripheral blood mononuclear cells in patients with perennial allergic asthma/rhinitis: relation to serum markers of apoptosis.
    Grzegorczyk J; Kowalski ML; Pilat A; Iwaszkiewicz J
    Mediators Inflamm; 2002 Aug; 11(4):225-33. PubMed ID: 12396474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation.
    Palermo A; Mulè G; Vadalà A; Vaccaro F; Guarneri M; Arsena R; Briolotta C; Cerasola G; Cottone S
    Nephrology (Carlton); 2008 Apr; 13(2):164-70. PubMed ID: 18275506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status.
    Norata GD; Baragetti I; Raselli S; Stucchi A; Garlaschelli K; Vettoretti S; Piloni G; Buccianti G; Catapano AL
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):56-63. PubMed ID: 19359150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD.
    Smith ER; Ford ML; Tomlinson LA; Rajkumar C; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2012 May; 27(5):1957-66. PubMed ID: 22105144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease.
    Hébert MJ; Masse M; Vigneault N; Sirois I; Troyanov S; Madore F
    Am J Kidney Dis; 2001 Dec; 38(6):1271-6. PubMed ID: 11728960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas expression in nephrectomized, non-cancerous specimens predicts post-nephrectomy chronic kidney disease progression in patients with renal and upper urinary tract malignancies.
    Sejima T; Iwamoto H; Morizane S; Hinata N; Yao A; Isoyama T; Saito M; Amisaki T; Takenaka A
    Urol Oncol; 2013 Nov; 31(8):1812-9. PubMed ID: 22591748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
    J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients.
    Gonçalves S; Pecoits-Filho R; Perreto S; Barberato SH; Stinghen AE; Lima EG; Fuerbringer R; Sauthier SM; Riella MC
    Nephrol Dial Transplant; 2006 Oct; 21(10):2788-94. PubMed ID: 16861246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and Progression of CKD: The CRIC Study.
    Amdur RL; Feldman HI; Gupta J; Yang W; Kanetsky P; Shlipak M; Rahman M; Lash JP; Townsend RR; Ojo A; Roy-Chaudhury A; Go AS; Joffe M; He J; Balakrishnan VS; Kimmel PL; Kusek JW; Raj DS;
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1546-1556. PubMed ID: 27340285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of fish oil supplementation on markers of inflammation in chronic kidney disease patients.
    Deike E; Bowden RG; Moreillon JJ; Griggs JO; Wilson RL; Cooke M; Shelmadine BD; Beaujean AA
    J Ren Nutr; 2012 Nov; 22(6):572-7. PubMed ID: 22285316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.